KLRC1 and B-cell chronic lymphocytic leukemia: Concerning the NK cell inhibitory receptors, it has been shown that CD94/NKG2A hampers NK cell cytotoxicity against CLL cells through the binding to HLA-E molecules [174], which are highly expressed on the CLL cell surface [37,174,175].